Cargando…
Hyperkalemia After Initiating Renin–Angiotensin System Blockade: The Stockholm Creatinine Measurements (SCREAM) Project
BACKGROUND: Concerns about hyperkalemia limit the use of angiotensin‐converting enzyme inhibitors (ACE‐I) and angiotensin receptor blockers (ARBs), but guidelines conflict regarding potassium‐monitoring protocols. We quantified hyperkalemia monitoring and risks after ACE‐I/ARB initiation and develop...
Autores principales: | Bandak, Ghassan, Sang, Yingying, Gasparini, Alessandro, Chang, Alex R., Ballew, Shoshana H., Evans, Marie, Arnlov, Johan, Lund, Lars H., Inker, Lesley A., Coresh, Josef, Carrero, Juan‐Jesus, Grams, Morgan E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586281/ https://www.ncbi.nlm.nih.gov/pubmed/28724651 http://dx.doi.org/10.1161/JAHA.116.005428 |
Ejemplares similares
-
Plasma potassium ranges associated with mortality across stages of chronic kidney disease: the Stockholm CREAtinine Measurements (SCREAM) project
por: Gasparini, Alessandro, et al.
Publicado: (2019) -
The Stockholm CREAtinine Measurements (SCREAM) project: protocol overview and regional representativeness
por: Runesson, Björn, et al.
Publicado: (2016) -
Albuminuria and the risk of cancer: the Stockholm CREAtinine Measurements (SCREAM) project
por: Luo, Li, et al.
Publicado: (2023) -
Causes of death across categories of estimated glomerular filtration rate: The Stockholm CREAtinine Measurements (SCREAM) project
por: Runesson, Björn, et al.
Publicado: (2019) -
Novel glucose-lowering drugs and the risk of acute kidney injury in routine care; the Stockholm CREAtinine Measurements (SCREAM) project
por: Alkas, Jim, et al.
Publicado: (2022)